Wilson's disease A Ala, AP Walker, K Ashkan, JS Dooley, ML Schilsky The Lancet 369 (9559), 397-408, 2007 | 1529 | 2007 |
Elafibranor, an agonist of the peroxisome proliferator− activated receptor− α and− δ, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening V Ratziu, SA Harrison, S Francque, P Bedossa, P Lehert, L Serfaty, ... Gastroenterology 150 (5), 1147-1159. e5, 2016 | 1110 | 2016 |
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ... The Lancet 394 (10215), 2184-2196, 2019 | 1059 | 2019 |
The UK‐PBC risk scores: derivation and validation of a scoring system for long‐term prediction of end‐stage liver disease in primary biliary cholangitis M Carbone, SJ Sharp, S Flack, D Paximadas, K Spiess, C Adgey, ... Hepatology 63 (3), 930-950, 2016 | 374 | 2016 |
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways HJ Cordell, Y Han, GF Mells, Y Li, GM Hirschfield, CS Greene, G Xie, ... Nature communications 6 (1), 8019, 2015 | 303 | 2015 |
Increased prevalence of primary biliary cirrhosis near Superfund toxic waste sites A Ala, CM Stanca, M Bu‐Ghanim, I Ahmado, AD Branch, TD Schiano, ... Hepatology 43 (3), 525-531, 2006 | 277 | 2006 |
Wilson disease in septuagenarian siblings: raising the bar for diagnosis A Ala, J Borjigin, A Rochwarger, M Schilsky Hepatology 41 (3), 668-670, 2005 | 229 | 2005 |
Bis-choline tetrathiomolybdate in patients with Wilson's disease: an open-label, multicentre, phase 2 study KH Weiss, FK Askari, A Czlonkowska, P Ferenci, JM Bronstein, D Bega, ... The Lancet Gastroenterology & Hepatology 2 (12), 869-876, 2017 | 145 | 2017 |
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score M Carbone, A Nardi, S Flack, G Carpino, N Varvaropoulou, C Gavrila, ... The Lancet Gastroenterology & Hepatology 3 (9), 626-634, 2018 | 128 | 2018 |
Wolman's disease and cholesteryl ester storage disorder: the phenotypic spectrum of lysosomal acid lipase deficiency M Pericleous, C Kelly, T Wang, C Livingstone, A Ala The lancet Gastroenterology & hepatology 2 (9), 670-679, 2017 | 128 | 2017 |
Wilson disease ML Schilsky, A Ala Schiff's Diseases of the Liver, 799-819, 2017 | 119 | 2017 |
Role of cell adhesion molecules in leukocyte recruitment in the liver and gut A Ala, AP Dhillon, HJ Hodgson International journal of experimental pathology 84 (1), 1-16, 2003 | 111 | 2003 |
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs HJ Cordell, JJ Fryett, K Ueno, R Darlay, Y Aiba, Y Hitomi, M Kawashima, ... Journal of hepatology 75 (3), 572-581, 2021 | 90 | 2021 |
Wilson disease: pathophysiology, diagnosis, treatment, and screening A Ala, ML Schilsky Clinics in liver disease 8 (4), 787-805, 2004 | 66 | 2004 |
Prospective pilot study of a single daily dosage of trientine for the treatment of Wilson disease A Ala, E Aliu, ML Schilsky Digestive diseases and sciences 60, 1433-1439, 2015 | 58 | 2015 |
Hepatic features of Wilson disease S Boga, A Ala, ML Schilsky Handbook of clinical neurology 142, 91-99, 2017 | 52 | 2017 |
Biomedical copper speciation in relation to Wilson’s disease using strong anion exchange chromatography coupled to triple quadrupole inductively coupled plasma mass spectrometry N Solovyev, A Ala, M Schilsky, C Mills, K Willis, CF Harrington Analytica Chimica Acta 1098, 27-36, 2020 | 43 | 2020 |
towards a considered and ethical approach to organ support in critically‐ill patients with cirrhosis PA Berry, SJ Thomson, TM Rahman, A Ala Alimentary pharmacology & therapeutics 37 (2), 174-182, 2013 | 42 | 2013 |
Recommendations for the management of secondary hypogammaglobulinaemia due to B cell targeted therapies in autoimmune rheumatic diseases S Wijetilleka, DR Jayne, C Mukhtyar, A Ala, PD Bright, H Chinoy, L Harper, ... Rheumatology 58 (5), 889-896, 2019 | 40 | 2019 |
Greater transplant-free survival in patients receiving obeticholic acid for primary biliary cholangitis in a clinical trial setting compared to real-world external controls CFM Perez, H Fisher, S Hiu, D Kareithi, F Adekunle, T Mayne, E Malecha, ... Gastroenterology 163 (6), 1630-1642. e3, 2022 | 39 | 2022 |